Gene Therapy Clinical Development Considerations
Mantej (Nimi) Chhina, Senior Director & Head, Global Regulatory Policy, BioMarin Pharmaceutical Inc.
Ilan Irony, Deputy Director, Division of Clinical Evaluation and Pharmacology/Toxicology, CBER, FDA
Gopa Raychaudhuri, Senior Scientist, Office of the Center Director, CBER, FDA
Moderated by Michael N. Druckman, Partner, Hogan Lovells US LLP
Watch this session: https://fdli.vids.io/videos/119ddbb61d19e3c898/regenerative-medicine-conference-day-1-session-5-gene-therapy-clinical-development-considerations